Merrill Lynch Downgrades AptarGroup (ATR) to Neutral
More News related to ATR
- Matrix Upgrades and Downgrades for November 25, 2008
- Notable Analyst Rating Changes 11/20: DSX, BIDU, ATR Upgraded; EGLE, SOL, AMED, PAY Downgraded
- Merrill Lynch Upgrades AptarGroup (ATR) to Buy
- AptarGroup (ATR) Reports In-Line Q3 EPS of $0.57; Guides Q4 Below the Street; Declares Qtr. Dividend of $0.15/Share
- AptarGroup Reports Record Results Driven by Strong Pharma Business; Declares Dividend
More News related to Downgrades
- B. Riley Downgrades Doral Financial (DRL) to Neutral
- CL King Downgrades Ceragon (CRNT) to Accumulate
- Matrix Upgrades/Downgrades for December 1, 2008
- Raymond James Downgrades Allscripts (MDRX) to Market Perform
- RBC Capital Downgrades Strategic Hotels & Resorts (BEE) to Underperform
Merrill Lynch downgrades AptarGroup (NYSE: ATR) from Buy to Neutral.
AptarGroup, Inc. (AptarGroup) is a supplier of a range of dispensing systems for the personal care, fragrance/cosmetic, pharmaceutical, household and food/beverage markets.
Related Categories
DowngradesStocks Mentioned
-3.45Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
